Jenna M Sullivan
5PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 13, 2026
WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins.Christopher J Nirschl, Kulandayan K Subramanian, Heather R Brodkin
|Apr 19, 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity.Christopher J Nirschl, Heather R Brodkin, Celesztina Domonkos
|Mar 14, 2022
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression.Christopher J Nirschl, Heather R Brodkin, Daniel J Hicklin
|Dec 07, 2018
Cutting Edge: Dynamic Expression of Id3 Defines the Stepwise Differentiation of Tissue-Resident Regulatory T Cells.Jenna M Sullivan, Barbara Höllbacher, Daniel J Campbell
|Aug 11, 2018
B cell adaptor for PI3-kinase (BCAP) modulates CD8+ effector and memory T cell differentiation.Mark D Singh, Minjian Ni, Jenna M Sullivan
Pageof 1
Frequent Collaborators
3 joint publications
Nesreen S Ismail
3 joint publications
Cynthia Seidel-Dugan
3 joint publications
Andres Salmeron
2 joint publications
William M Winston
2 joint publications
Christopher J Nirschl
2 joint publications
Heather R Brodkin
2 joint publications
Celesztina Domonkos
2 joint publications
Connor J Dwyer
2 joint publications
Daniel J Hicklin
2 joint publications
Zoe Steuert
